Immune Cells May Facilitate Tumor Growth
News Nov 14, 2016
A new study led by scientists at The Scripps Research Institute (TSRI) suggests there may be a way to limit tumor growth by targeting immune system cells called macrophages.
The research reveals that macrophages can “drill” through tumors to create new vessel-like structures for delivering oxygen and nutrients as tumors grow.
“This may represent a whole new therapeutic target for treating tumors,” said TSRI Professor Martin Friedlander, senior author of the new study, which was published November 11 in the journal Scientific Reports.
A Different Kind of Vessel
Blood vessels are normally built by endothelial cells. In cancer, tumor cells can induce endothelial cells to build new vessels to bring in blood rich with oxygen and nutrients, a process called angiogenesis.
Recent research has revealed that not all vessels are lined by endothelial cells. In cancer, vessel-like structures can be created by a non-endothelial cell type. This phenomenon, called “vascular mimicry,” has been observed in several types of solid tumors, including glioblastoma, breast cancer and melanoma, and has been attributed to a sub-population of cells within the tumor called cancer stem cells.
Yet the scientists in this study found that macrophages can form vascular mimicry channels in tumors, as well as in other low-oxygen environments. Although macrophages are key cells of the immune system that recognize and attack foreign invaders and cancer cells, macrophages can be re-programmed within the tumor environment to promote tumor growth.
The scientists in the new study presented a new and unrecognized structural role for macrophages in the formation of a vascular mimicry network connected to the systemic circulation.
“These conduits have an architecture distinct from that of traditional blood vessels,” said Faith H. Barnett, a cancer researcher and neurosurgeon at Scripps Clinic who served as co-first author of the study with Mauricio Rosenfeld.
Using an intravenously injected dye to delineate the established vasculature as well as the newly formed vascular mimicry conduits, the researchers found that macrophages quickly migrate to oxygen-deprived environments and form these vessel-like channels. Experiments spearheaded by Barnett and Rosenfeld showed that these tubular structures are lined with cells that express macrophage cell surface markers.
“Macrophages are capable of forming a three-dimensional network,” said Rosenfeld.
These vessel-like channels appeared too small to carry red blood cells, but the researchers believe that the low oxygen concentrations within tumors drive macrophages to form this network of channels to transport dissolved oxygen and glucose.
A Possible Cancer Target
The findings could explain why current drugs to slow angiogenesis do not slow tumor growth in some patients. Friedlander said future cancer therapies could starve tumors by combining current vessel-targeting drugs with drugs to influence macrophage activity.
“There may be an opportunity to intervene therapeutically,” Friedlander said.
Story from The Scripps Research Institute. Please note: The content above may have been edited to ensure it is in keeping with Technology Networks’ style and length guidelines.
Barnett, F. H., Rosenfeld, M., Wood, M., Kiosses, W. B., Usui, Y., Marchetti, V., … Friedlander, M. (2016). Macrophages form functional vascular mimicry channels in vivo. Scientific Reports, 6, 36659. doi:10.1038/srep36659
Targeting the Engine Room of the Cancer CellNews
Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug combinations that are most likely to kill them.READ MORE
Cryo-EM Reveals Interaction Between Major Drug TargetsNews
For the first time, scientists have visualized the interaction between two critical components of the body's vast cellular communication network, a discovery that could lead to more effective medications with fewer side effects for conditions ranging from migraine to cancer.READ MORE
Comments | 0 ADD COMMENT
27th International Conference on Nanomedicine and Nanomaterials
Oct 18 - Oct 19, 2018